PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Recently Added NEW Latest cases added to the library
AUTH/3282/11/19
Gilead Sciences Europe
Social Media & Digital · 2019
▶ Video 🎧 Podcast
AUTH/2991/11/17
Pfizer
Samples & Gifts · 2015
▶ Video 🎧 Podcast
AUTH/2082/1/08
Recordati Pharmaceuticals
Promotional Material · 2019
▶ Video 🎧 Podcast
AUTH/2079/1/08
Gamble Pharmaceuticals UK
Transfers of Value · 2008
▶ Video 🎧 Podcast
AUTH/2102/2/08
Meda Pharmaceuticals
Transfers of Value · 2008
▶ Video 🎧 Podcast
AUTH/2149/7/08
Syner-Med
Promotional Material · 2008
▶ Video 🎧 Podcast
AUTH/2428/8/11
AstraZeneca
Scientific Information · 2008
▶ Video 🎧 Podcast
AUTH/1899/10/06
AstraZeneca
Samples & Gifts · 2019
▶ Video 🎧 Podcast
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/3886/3/24
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Moderna Biotech UK Ltd
A complaint (on behalf of Children’s Covid Vaccines Advisory Council) alleged an inappropriate financial inducement was used to recruit children into Moderna’s NextCOVE COVID booster vaccine cl…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3870/1/24
Data & Publications Upheld 🏥 Other ▶ Video 🎙 Podcast
AstraZeneca
A complaint was made against AstraZeneca concerning allegations about clinical trial material.The PMCPA determined the matter was outwith the scope of the ABPI Code of Practice.
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3875/02/24
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
LinkedIn post mentioning Arexvy in financial results video (No breach)
An anonymous, non-contactable complainant alleged a GSK global leader improperly mentioned a product name in a LinkedIn post visible to the public, amounting to promotion of a prescription-only med…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3873/01/24
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Bayer
An anonymous, non-contactable complainant (self-described health professional) said a patient brought a printout of the Eylea Summary of Product Characteristics (SmPC/SPC).The patient allegedly fou…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3874/02/24
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (ex-employee) alleged a public LinkedIn post and profile headline named three Sanofi prescription medicine brand names as part of a job title.The post was …
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3871/1/24
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AbbVie breach for inaccurate SPC presentation on EMC
An anonymous, non-contactable health professional complained about a formatting error in the Venclyxto (venetoclax) 100mg SPC on the EMC website.In section 4.2 (Posology and method of administratio…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3879/2/24
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Pfizer
An independent cancer research charitable organisation posted on LinkedIn about “a new drug, talazoparib” becoming an NHS targeted treatment for advanced breast cancers caused by BRCA mutations…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3905/5/24
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Nexplanon ad and linked website challenged for missing contraindications (no breach)
An anonymous, contactable healthcare professional complained about a Nexplanon advertisement shown on a closed community professional network for UK doctors.The complainant alleged the ad omitted �…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3911/5/24
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Theramex
A complaint was made about the ‘About Us’ section of Theramex’s corporate LinkedIn page.The page stated: “A new global women’s healthcare company that provides innovative, effective and s…
Clauses: 4.1
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3891/4/24
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AbbVie breached Clause 8.5 after failing to recertify an AbbVie Pro landing page within two years (A
An anonymous, non-contactable complainant (member of the public/media) alleged that an AbbVie Pro oncology webpage showed a certification date of May 2020 and had not been recertified within two ye…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3889/4/24
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
An anonymous, contactable complainant challenged a promotional email for Xarelto (rivaroxaban) sent by a third party on Bayer’s behalf to verified UK general practitioners.The complainant alleged…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3896/5/24
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Roche
An anonymous, contactable health professional complained that a UK patient organisation’s self-management programme materials did not clearly declare Roche’s involvement “from the outset”.T…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3888/4/24
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Pfizer
A member of the public complained about a Pfizer UK Twitter (now X) thread dated 19 November 2020 about Phase 3 results for Pfizer’s Covid-19 vaccine candidate, and a retweet by a senior Pfizer e…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3913/5/24
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Idorsia
An anonymous, contactable complainant (a concerned healthcare professional) complained about Idorsia’s UK HCP portal website (pro.idorsia.uk).Allegation 1: The landing page offered two self-selec…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3920/6/24
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
A named complainant (describing themselves as a physician) complained about content in the ‘Experience’ section of a senior AstraZeneca employee’s LinkedIn profile.The complainant alleged the…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3926/6/24
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Pfizer
Two LinkedIn posts (one by a UK health authority, one by its employee) discussed NICE final draft guidance and named Pfizer’s medicine voxelotor, linking to a health authority website article.The…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3901/5/24
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Complainant v GSK
A health professional complained about four webpages within GSK’s UK HCP promotional site (GSKPro) for Jemperli (dostarlimab). They alleged the mobile versions differed from desktop (text colour/…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3892/4/24
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
AstraZeneca Twitter/X posts about Covid-19 vaccine
An anonymous, contactable complainant alleged AstraZeneca’s UK corporate Twitter/X account posted items promoting its Covid-19 vaccine to the public and amounting to pre-licence promotion.The com…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3917/6/24
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Jazz Pharmaceuticals
An anonymous, contactable health professional complained about two Jazz-funded online presentations for UK health professionals about Epidyolex (cannabidiol).Video 1 (“Understanding the Pharmacol…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3918/6/24
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Jazz Pharmaceuticals UK breached ABPI Code over
An anonymous (later non-contactable) health professional complained about a 39m 35s Jazz-funded promotional video for UK health professionals about Epidyolex (cannabidiol), featuring three speakers…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3904/5/24
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Gedeon Richter
A healthcare professional complained about an Evra (norelgestromin/ethinyl estradiol) promotional advertisement shown on a closed UK doctors’ network.The complainant alleged the ad omitted “key…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3880/2/24
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Complainant v GSK
A concerned health professional complained about a LinkedIn post announcing GSK’s acquisition of Aiolos Bio and referencing investigational molecule AIO-001 “in asthma and potentially other ind…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3882/2/24
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Evolus website
An unverified health professional complained about Evolus’ publicly accessible company website and HCP Nuceiva (botulinum toxin type A) pages, alleging the site blurred corporate “beauty” mes…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3893/4/24
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Roche
An anonymous, contactable complainant alleged a healthcare partnership website did not prominently declare Roche sponsorship “from the outset”, with the declaration only appearing at the end of…
Clauses: NONE
2024 🔒 Subscribe
1 2 3 4 Next → Page 1 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews